NCT07157553Not yet recruiting
Effect of Argon Laser Panretinal Photocoagulation on Corneal Endothelial Cell Density .
Effect of Argon Laser Panretinal Photocoagulation on Corneal Endothelial Cell Density Among Patients With Proliferative Diabetic Retinopathy .
Source: ClinicalTrials.gov · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study investigates the effect of argon laser panretinal photocoagulation (PRP) on the corneal endothelial cell density (ECD) in patients with proliferative diabetic retinopathy (PDR) by comparing ECD measurements before and after PRP treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 45 (estimated)
- First submitted
- 28 Aug 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- Assiut University
- Diseases
- Diabetic eye disease
- NCT number
- NCT07157553
What you commit to
- Study type: Observational
- Planned participants: 45
- From 1 Oct 2025 to the primary completion date, 30 Nov 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous intraocular surgery
Other illness
- history of corneal disease
Other
- glaucoma or intraocuar inflamation .
Who the study is looking for
- Patients from either sex with any age newly diagnosed PDR requring PRP .
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.